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Resistance to antibiotics has become a major concern for
microbiologists, biochemists, and physicians worldwide. A
report with the conclusions of a Workshop held at Rockefeller
University in 1994 showed that several bacterial strains isolated
from clinical specimens were resistant to all currently available
antibiotics. This set off an alarm as to the dimensions of a
possible environmental disaster if there were a diffusion of
such human pathogens. These literally drug-immortal bacteria
are a serious threat to human populations at the threshold of
the 21st century. In 1996 WHO reported that the previous year
33% of the 52 million worldwide deaths were caused by
infectious diseases. Since 1973, more than 30 emerging
microorganisms (new infectious agents) have been identified.
Examples of such new pathogens are: Legionella pneumophila,
causing legionellosis; Cryptosporidium parvum, causing acute
and chronic diarrhea; Vibrio cholerae O139, a new strain
causing the recent cholera epidemic outbreaks; the human
immunodeficiency virus (HIV); human herpes virus 8; Borrelia
burgdorferi, causing Lyme disease; and the Ebola virus. Strong
ecological pressures on our overpopulated planet and the free
mobility of entire human populations have contributed to the
emergence of new infectious diseases.
The “resurrection” of bacterial pathogens is another major
concern we have witnessed recently. Among reemerging
bacteria are the causing agents of pneumonia (a group of
bacteria that cause acute respiratory infections and are
responsible for 4.4 million deaths per year), of tuberculosis
(more than 3 million deaths per year), cholera, and yellow fever.
In the United States, enterococci have become the third major
nosocomial pathogen to produce endocarditis. By 1993,
vancomycin, which had been an antibiotic used as a last resort
against ultra-resistant bacterial strains, was already ineffective
against many Enterococcus faecalis strains. Similarly,
Staphylococcus aureus strains resistant to methicillin rose from
8% in 1986 to 40% in 1992.
Reemerging pathogens such as Neisseria meningitidis and
Streptococcus pneumoniae have acquired new strategies for
antibiotic resistance based on genetic exchange between
different serotypes of certain virulence factors present in
microorganisms. Such strategies comprise the formation of
mosaic structures which alter the PBPs (penicillin-binding
proteins) of the membrane or make it possible for the pathogen
to escape the immunological protection acquired by vaccination.
Characterization of the genes coding for the formation of the
polysaccharide capsules that surround N. meningitidis showed
that they had been the cause of very virulent outbreaks of
meningococcal meningitis detected in the states of Oregon and
Washington in the late 1990s. A change from serotype b 
to serotype c had taken place. The people, who had been
inoculated against serotype b, were defenseless against serotype
c, and a major outbreak occurred. Epidemic outbreaks caused
by S. pneumoniae, that originated from similar variations in
the capsular types, had also been documented.  The complexity
of capsulated bacteria adds to the presence of antibiotic resistant
genes providing the bacteria with more weapons to develop
epidemic outbreaks.
Therefore, both ecological factors and the genetic
characteristics of each pathogen play decisive roles in the
emergence of infectious diseases. When penicillin started to
be widely used in the mid-1940s, pneumococci were very
sensitive to this antibiotic. It took some twenty years for the
first resistant mutant to be isolated (1967, in Papua-New
Guinea). The stabilization of genetic determinants of resistance
is usually a long process, but once resistance is acquired, it
spreads quickly. In the long run, strategies to defeat reemerging
pathogens will have to involve a rational use of antimicrobial
drugs as well as changes in social behavior, new public health
regulations and information campaigns. Besides, in-depth
knowledge of the specific mechanisms of resistance is essential
to develop new antimicrobial agents. To acquire this knowledge,
basic molecular and physiological research must look into the
changes that infectious agents develop continuously in their
natural habitats.
The main step that must be taken to fight reemerging
diseases is to develop basic microbiology. We must also
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intensify health measures, train health personnel, and promote
the search for new antimicrobial drugs, thus expanding our
knowledge of microbial diversity. Research on microorganisms
that can grow at high temperatures has led to the isolation of
enzymes such as the Taq polymerase, which have revolutionized
traditional laboratory techniques through the extensive use
of the polymerase chain reaction. This close relationship with
laboratory techniques has demonstrated it is mandatory to
prepare scientists that are experts in physiology and taxonomy.
Combining molecular biology and phylogeny is a
fundamental step for a better knowledge of the natural microbial
world and microbial diversity without the need to isolate and
grow species. This kind of research might help us to differentiate
between the 3,000 bacterial species described in the Bergey’s
Manual and the hundreds of thousands of species suggested by
microbial ecologists that study microorganisms in their natural
habitats. By using molecular probes containing genes that code
for rRNA (16S in prokaryotes and 18S in eukaryotes), a new
classification of living beings has been postulated. This new
classification comprises three large Domains: Bacteria, Archaea,
and Eukarya. Homologies among microorganisms established
with this new methodology and those coming from the studies
in axenic cultures have generated an enormous amount of valuable
information. Ecologists agree that this method of analysis of gene
sequences will lead to a means of global comparison of microbial
diversity, and will facilitate the discovery of new organisms. 
Bacteriophages were a fundamental tool in the development
of molecular biology and applied microbiology over several
decades. Afterwards, interest in studying their economic impact
in the food industry seemed to have declined. In the 1990s,
however, phages have been again in the spotlight due to the
role they play in the transference of virulence genes. This kind
of transference and the horizontal gene transfer play a major
role in the transmission of “pathogenicity islands,” which seem
to perform a basic function in the infectious process. The
transfer of two genes coding for specific toxins by means of
a temperate phage accounts for the virulence of Escherichia
coli O157:H7, which caused outbreaks of hemorrhagic colitis
in the United States, the United Kingdom and Japan. The
incorporation of a filamentous phage (CTXO|) coding for a new
toxin to the El Tor pathovar of Vibrio cholerae has produced
a new strain (O139) still more virulent. The above examples
of molecular changes in bacteria are mechanisms that increase
both their pathogenic capability and their chances of overall
survival. Besides, our chances of exterminating them with 
the means currently available (vaccines, antibiotics) are
continuously decreasing.
A new field of research suggests that bacteriophages might
be useful therapeutic agents. This is a revival of the original
ideas of the phages’ discoverers, at the beginning of the 20th
century. Joshua Lederberg has pointed out that this kind of
experimental approach is still far beyond our reach due to
several limitations in the present technology. He has spelled
out, however, the existing limitations in the interactions of
microorganisms and mammal cell lines.
Once again, using E. coli as a model, scientists have reported
that its functions within the intestinal tract can be modified
to transform the beneficial microorganism either into an
enteropathogen or a uropathogen. Bacterial tropism is
determined by a cassette of genes (pathogenicity islands) that
is incorporated in a specific point of the chromosome in E. coli.
Genetic transmission of genes in block has been termed
evolution by quantum leaps. Another example of this type of
gene transfer mechanism can be found in Helicobacter pylori.
Strains isolated from patients with gastric ulcer contain a 
40 kb fragment of DNA that is absent in the strains obtained
from asymptomatic infected patients. Besides, now we know
that these pathogenic genes are only expressed when
environmental and regulatory conditions are favorable.
Therefore, although the virulence genes might be incorporated
from an outside organism, the mechanisms that regulate their
activity and expression already exist and continue to be
functionally active in the recipient cell.
The alarming reemergence of several infectious diseases
makes it necessary to establish strong interdisciplinary links
between researchers. The study of infection as an ecological
process will surely be crucial for the control of microorganisms.
Long-term measures should be based both on accurate basic
research of the evolution of resistance and on molecular analyses
that provide information on the intra- and interspecific
transmission of virulence genes. In the meantime, prevention
is the most sensible measure—both from the economic and
medical point of view—to control infectious diseases. 
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